Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2021. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 147211000087110 | INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 147221000087119 | INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 147231000087117 | Inf INFLUSPLIT TETRA GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has product characteristic | Unadjuvanted vaccine product (qualifier value) | true | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has supplier | GlaxoSmithKline Biologicals (supplier) | true | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | a pour principe actif (attribut) | Antigen of Influenza B virus Victoria lineage split virion (substance) | true | Inferred relationship | Some | 3 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient characteristic (attribute) | Standard dose (qualifier value) | false | Inferred relationship | Some | 4 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Count of active ingredient | quatre | false | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient characteristic (attribute) | Standard dose (qualifier value) | false | Inferred relationship | Some | 2 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | est un(e) (attribut) | Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | a pour principe actif (attribut) | Antigen of Influenza A virus subtype H1N1 split virion (substance) | true | Inferred relationship | Some | 1 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | a pour principe actif (attribut) | Antigen of Influenza B virus Yamagata lineage split virion | true | Inferred relationship | Some | 4 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient characteristic (attribute) | Standard dose (qualifier value) | false | Inferred relationship | Some | 1 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | a pour principe actif (attribut) | Antigen of Influenza A virus subtype H3N2 split virion (substance) | true | Inferred relationship | Some | 2 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient characteristic (attribute) | Standard dose (qualifier value) | false | Inferred relationship | Some | 3 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | Standard dose (qualifier value) | true | Inferred relationship | Some | 4 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | Standard dose (qualifier value) | true | Inferred relationship | Some | 3 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | Standard dose (qualifier value) | true | Inferred relationship | Some | 1 | |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) | Has ingredient qualitative strength | Standard dose (qualifier value) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR